Summary
We observed a 23-year-old man with pronounced hyperkalemia (max. 6.8 mmol/l) and hyponatremia (min. 112 mmol/l), which had been existent for 3 years without complaint except a transitory psychorganic syndrome due to hyponatremia. Physical examination showed no abnormality except hypotension (blood pressure 100/70 mmHg). Renal function tests were normal. Fractional clearance of sodium was significantly increased (0.8%), whereas that of potassium was decreased (2.4%). Plasma renin activity was tripled and rose after furosemide. Plasma aldosterone was lowered and showed no rise after furosemide. Suppression of plasma renin and aldosterone by saline infusion was normal. Pressor dose of angiotensin II was increasend (17,9 ng AT II/kg/min). Urinary excretion of aldosterone and its conjugates was below normal, and aldosterone precursors were within normal range. The findings were interpreted as selective primary hypoaldosteronism caused by corticosterone methyl oxidase defect type II. However, neither fludrocortisone (0.5 mg/day) nor sodium chloride (200 mmol/day) led to a normalization of sodium and potassium in plasma. Additional pseudohypoaldosteronism was thus assumed. Aldosterone infusion (3 mg in 1 h) decreased renal excretion of sodium; potassium excretion failed, however, to increase in contrast to its pattern in normal man. These findings resemble additional pseudohypo-aldosteronism of type II. After 8 weeks' application of additional 80 mmol sodium (as sodium bicarbonate) plasma sodium and potassium showed normal values under combined treatment with fludrocortisone (0.1 mg/day) and sodium bicarbonate (80 mmol/day). It is to be assumed that the patient suffers from a reduced aldosterone biosynthesis in the presence of an additional transitory secondary pseudohypoaldosteronism.
Similar content being viewed by others
Literatur
Arnold JE, Healy JK (1969) Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 47:461
Batlle D, Grupp M, Gaviria M, Kurtzmann NA (1982) Distal renal tubular acidosis with intact capacity to lower urinary pH. Am J Med 72:751
Bierich JR, Schmidt U (1976) Tubular Na, K-ATPase deficiency, the cause of the congenital renal salt-losing syndrome. Eur J Pediatr 121:81
Cheek DB, Perry JW (1958) A salt wasting syndrome in infancy. Arch Dis Child 33:252
Claeson G, Friberger P, Knös M, Eriksson E (1978) Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Haemostasis 7:76
Cogan MC, Arieff AJ (1978) Sodium wasting, acidosis and hyperkalemia, induced by methicillin interstitial nephritis. Am J Med 64:500
David RR, Asnis M, Drucker WD (1972) Disturbance of cortisol production in congenital aldosterone deficiency. J Clin Endocrinol Metab 35:604
Kaplan NM, Silah JG (1964) The angiotensin infusions test. New Engl J Med 271:536
Krozowski Z, Stephenson G, Quirk S, Funder J (1983) Mineralocorticoid receptors and extrinsic specifity conferring mechanism. In: Kaufmann W (ed) Mineralocorticoids and hypertension. Springer, Berlin Heidelberg New York, pp 3–9
Rösler A, Rabinowitz D, Theodor R, Ramirez L, Ulick S (1977) The nature of the defect in a salt wasting disorder in Jews of Iran. J Clin Endocrinol Metab 44:279
Rössler R, Hornef W, Klaus D, Simsch A (1971) Bestimmung der Plasmareninaktivität durch radioimmunologischen Nachweis von Angiotensin I. Klin Wochenschr 49:870
Schambelan M, Sebastian A, Rector FC Jr (1981) Mineralocorticoid-resistant renal hyperkalemia without salt wasting (typ II pseudohypoaldosteronism). Kidney Int 19:716
Schambelan M, Sebastian A, Hulter HN (1978) Mineralocorticoid excess and deficiency syndromes. In: Brenner BM, Stein JH (eds) Contemporary issues in nephrology, vol II. Churchill-Livingstone, New York, p 232
Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M (1982) Disorders of distal nephron function. Am J Med 72:289
Silva P, Hayslett JP, Epstein FH (1973) The role of Na-K-activated adenosine triphosphatase in potassium adaptation. J Clin Invest 52:2665
Sonnenblick EH, Cannon PJ, Laragh JH (1961) The nature of the action of intravenous aldosterone: evidence for a role of the hormone in urinary diluation. J Clin Invest 40:903
Spitzer A, Edelmann CM Jr, Goldberg LD, Henneman PH (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251
Ulick S, Nicolis GL, Vetter KK (1964) Relationship of 18-hydroxycorticosterone to aldosterone. In: Baulieu EG, Robel P (eds) Aldosterone. Blackwell, Oxford, pp 3–24
Vecsei P, Gless KH (1975) Aldosteron-Radioimmunoassay. Enke, Stuttgart
Veldhuis JD, Melby JC (1981) Isolated aldosterone deficiency in man. Endocr Rev 2:495
Veldhuis JD, Kulin HE, Santen RJ, Wilson TE, Melby JC (1980) Inborn error in the terminal step of aldosterone biosynthesis: Corticosterone methyloxidase defect type II. New Engl J Med 303:117
Weinstein SF, Allan DME, Mendoza SA (1974) Hyperkaliemia, acidosis, and short stature, associated with a defect in renal potassium excretion. J Pediatr 85:355
Westenfelder C, Birch FM, Baranowski RL (1980) Effect of Na-K-ATPase inhibition on hydrogen ion and potassium secretion. Pflügers Arch 386:161
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klaus, D., Lederle, R.M. & Vecsei, P. Primärer Hypoaldosteronismus und sekundärer Pseudo-Hypoaldosteronismus. Klin Wochenschr 62, 753–758 (1984). https://doi.org/10.1007/BF01721772
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721772